ImmunoGen announces senior management promotions
This article was originally published in Scrip
Executive Summary
ImmunoGen (US), a biotechnology company developing targeted anticancer products, has promoted Daniel Junius from executive vice-president and chief financial officer to president and chief operating officer. Dr John Lambert has been named executive vice-president of R&D and will continue as ImmunoGen's chief scientific officer.